JPMorgan’s Capital‑Raising and Structured Products Face Scrutiny Over Hidden Risks and Governance Concerns
JPMorgan Chase’s latest 424(b)(2) filings reveal a push for capital growth while selling structured notes with higher-than‑average rates and hidden commodity risks, raising concerns about transparency, investor safety, and potential bias in internal…
4 minutes to read










